A rapid and inexpensive point of care diagnostic for SARS-CoV-2 infection
$354,825R01FY2020EBNIH
Stanford University, Stanford CA
Investigators
Linked publications & trials
Paper 38941307Paper 38766164Paper 38457961Paper 37252358Paper 36564249Paper 35228728Paper 35026106Paper 33570381Paper 33443161Paper 33199876Paper 33175516Paper 32989286Paper 32726586Paper 32589815
Abstract
Project Summary The project outlines our plans to develop a rapid, point-of-care diagnostic test for the novel SARS-CoV-2 virus that can be used in resource-limited locations. The foundation of the project is a highly selective chemiluminescent reporter probe that produces light when activated by the major viral protease SARS-CoV-2 Mpro. This approach will enable rapid testing (<30 min) of easily obtained clinical samples (i.e., saliva) using a detector that has limited power needs and that can interface with standard smart phones to provide a diagnosis.
View original record on NIH RePORTER →